Ignite Creation Date:
2024-05-05 @ 6:36 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00512798
Status:
TERMINATED
Last Update Posted:
2012-10-02
First Post:
2007-08-06
Brief Title:
Bortezomib and Temozolomide in Treating Patients With Advanced Refractory Solid Tumors or Melanoma
Sponsor:
Vanderbilt-Ingram Cancer Center
Organization:
Vanderbilt-Ingram Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Solid Tumor |
| Brain and Central Nervous System Tumors |
| Melanoma |